Analysis of the UALCAN database revealed that CKS1B upregulation for LUAD and LUSC varied in individual cancer stages (Figures 3Ai, ii) due to patient ethnicity, sex, age, smoke addiction, tumor histology, nodal metastasis, and TP53 mutation status (Figure 3; Supplementary Tables S2, S3). Here, CKS1B is linked to neoplasm.